Executive Chairman Stephen West explains how AO-252, Coiled’s first-in-class oncology asset, could reshape Roquefort’s pipeline, transform shareholder value, and set the stage for an AIM relist with an eye on NASDAQ..
CEO, Enkhmaral Batkhuyag, shares how the company is leveraging advanced technology to transform microfinance in Central Asia, scale into new markets, and break ground with digital insurance...
CEO Tony Brewer outlines how the flooring distributor is pushing beyond its £160m run rate, growing like-for-like sales by over 10%, and doubling its dividend since 2021...
Cora Gold CEO Bert Monro outlines the company’s updated Sanankoro DFS — with a 26% reserve boost, rapid 1.1-year payback, and a hybrid solar plan set to cut costs and emissions...
XP Factory just posted a 30% jump in EBITDA, with both Escape Hunt and Boom Battle Bar gaining ground. CEO Richard Harpham sets out the roadmap to £100m in sales and 50%+ capital returns. High margins, high growth — and a compelling investor case...
Mark Thomas of Hardman & Co explains why Arbuthnot’s profit drop isn’t the full story — and where the real value creation is happening across its wealth, deposits, and specialist lending arms...
CEO Graeme Purdy shares a pivotal update on the company’s Stereax micro batteries as they complete manufacturing qualification and move into production...
EDX Medical Group Plc has joined forces with leading NHS and government health bodies to deliver a rapid hospital-acquired pneumonia test. Sir Chris Evans explains why this partnership could change patient outcomes, cut costs, and accelerate the UK’s precision medicine agenda...
TEAM plc Executive Chairman Mark Clubb has given an interview with DirectorsTalk, outlining the firm’s UCITS fund launch, HY25 interim results, and future outlook...
Vassilios Carellas breaks down the decision to raise equity now, the operational breakthroughs at Kiln 1, and how upcoming upgrades to Kilns 2, 3, and 4 aim to cement the company’s critical role in quicklime production..
CEO Andrew Hume walks us through a significant new agreement with Metals One, a deal that brings in capital and specialist partners while allowing Thor to retain upside exposure..
Stephane Foucaud of Auctus Advisors reveals how robust execution and a cash-rich balance sheet are fuelling both growth and shareholder value. Investors should keep Valeura firmly on their radar...
Graeme Purdy reveals how the company’s Goliath solid-state batteries, designed for electric vehicles, are now validated by OEM partners and on the cusp of generating commercial revenue...
Shahin Amini explains how the Prime Oil & Gas acquisition has doubled production, tripled dividends, and sharpened Meren’s focus on shareholder returns..
Executive Chairman Stephen West explains how AO-252, Coiled’s first-in-class oncology asset, could reshape Roquefort’s pipeline, transform shareholder value, and set the stage for an AIM relist with an eye on NASDAQ..
CEO, Enkhmaral Batkhuyag, shares how the company is leveraging advanced technology to transform microfinance in Central Asia, scale into new markets, and break ground with digital insurance...
CEO Tony Brewer outlines how the flooring distributor is pushing beyond its £160m run rate, growing like-for-like sales by over 10%, and doubling its dividend since 2021...
Cora Gold CEO Bert Monro outlines the company’s updated Sanankoro DFS — with a 26% reserve boost, rapid 1.1-year payback, and a hybrid solar plan set to cut costs and emissions...
XP Factory just posted a 30% jump in EBITDA, with both Escape Hunt and Boom Battle Bar gaining ground. CEO Richard Harpham sets out the roadmap to £100m in sales and 50%+ capital returns. High margins, high growth — and a compelling investor case...
Mark Thomas of Hardman & Co explains why Arbuthnot’s profit drop isn’t the full story — and where the real value creation is happening across its wealth, deposits, and specialist lending arms...
CEO Graeme Purdy shares a pivotal update on the company’s Stereax micro batteries as they complete manufacturing qualification and move into production...
EDX Medical Group Plc has joined forces with leading NHS and government health bodies to deliver a rapid hospital-acquired pneumonia test. Sir Chris Evans explains why this partnership could change patient outcomes, cut costs, and accelerate the UK’s precision medicine agenda...
TEAM plc Executive Chairman Mark Clubb has given an interview with DirectorsTalk, outlining the firm’s UCITS fund launch, HY25 interim results, and future outlook...
Vassilios Carellas breaks down the decision to raise equity now, the operational breakthroughs at Kiln 1, and how upcoming upgrades to Kilns 2, 3, and 4 aim to cement the company’s critical role in quicklime production..
CEO Andrew Hume walks us through a significant new agreement with Metals One, a deal that brings in capital and specialist partners while allowing Thor to retain upside exposure..
Stephane Foucaud of Auctus Advisors reveals how robust execution and a cash-rich balance sheet are fuelling both growth and shareholder value. Investors should keep Valeura firmly on their radar...
Graeme Purdy reveals how the company’s Goliath solid-state batteries, designed for electric vehicles, are now validated by OEM partners and on the cusp of generating commercial revenue...
Shahin Amini explains how the Prime Oil & Gas acquisition has doubled production, tripled dividends, and sharpened Meren’s focus on shareholder returns..
